Clinical Trials Browser

Phase 3 × Colonic Neoplasms × tislelizumab × Clear all

NCT07132008 2025-08-20

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT06332274 2025-05-13

UMBRELLA

Phase 3 Recruiting

GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma